| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014830584 |
| P356 | DOI | 10.1038/SJ.BJC.6604332 |
| P932 | PMC publication ID | 2361710 |
| P698 | PubMed publication ID | 18362933 |
| P5875 | ResearchGate publication ID | 5489329 |
| P2093 | author name string | T Kubota | |
| P2860 | cites work | Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine | Q28255790 |
| Proton therapy in clinical practice: current clinical evidence | Q33272793 | ||
| Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group | Q34572233 | ||
| S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial | Q34588472 | ||
| Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer | Q36614394 | ||
| Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats | Q41196248 | ||
| Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer | Q44956944 | ||
| Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies | Q45009121 | ||
| Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer | Q46941813 | ||
| Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group | Q73676552 | ||
| Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients | Q77809280 | ||
| Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug | Q78206833 | ||
| Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer | Q83895070 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | stomach neoplasm | Q4335552 |
| (RS)-tegafur | Q413370 | ||
| mechanism of action | Q3271540 | ||
| P304 | page(s) | 1301-1304 | |
| P577 | publication date | 2008-03-25 | |
| 2008-04-22 | |||
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | The role of S-1 in the treatment of gastric cancer | |
| P478 | volume | 98 |
| Q37889959 | A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma |
| Q37580903 | Advances in the pharmacological treatment of gastro-oesophageal cancer |
| Q39544715 | Calpain regulates thymidylate synthase-5-fluoro-dUMP complex levels associated with response to 5-fluorouracil in gastric cancer cells |
| Q37198610 | Chemoradiotherapy for treatment of esophageal cancer in Japan: current status and perspectives. |
| Q37832986 | Chemotherapy in the treatment of metastatic gastric cancer: is there a global standard? |
| Q35920858 | Cystoid macular edema associated with oral antineoplastic agent s-1 in a patient with diabetic retinopathy |
| Q36603976 | Development and validation of a HPLC-MS/MS method with electrospray ionization for quantitation of potassium oxonate in human plasma: Application to a pharmacokinetic study |
| Q35068015 | Economic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China |
| Q38075499 | Metastatic gastric cancer treatment: a little slow but worthy progress |
| Q38817753 | Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese. |
| Q38471350 | Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer |
| Q36230595 | S-1 and the treatment of gastric cancer with peritoneal dissemination |
| Q37454538 | S-1-based combination therapy vs S-1 monotherapy in advanced gastric cancer: a meta-analysis |
| Q26747708 | Taxanes in the Treatment of Advanced Gastric Cancer |
| Q37803170 | The extent of lymph node dissection for gastric cancer: A critical appraisal |
Search more.